Author

Matthew Parks

Primary ORCID profile (0000-0003-4283-9675 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Matthew ParksiD1 paper · Viome Life Sciences, Inc. (United States)

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:diffusion model· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Darren Jason HsuiD· 1 shared Duminda S. RanasingheiD· 1 shared Emine KüçükbenliiD· 1 shared Hok Hei TamiD· 1 shared Jayant Bhambhani· 1 shared Xin Yu· 1 shared Yuxing Peng· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Darren Jason HsuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Blind Virtual Screening at Scale: A Scalable End-to-End Pipeline for Blind Docking and Affinity Prediction

Matthew Parks, Xin Yu, Yuxing Peng, Jayant Bhambhani, Darren Jason Hsu, Duminda S. Ranasinghe, Emine Küçükbenli, Hok Hei Tam

This paper presents a scalable end-to-end pipeline for blind virtual screening using DiffDock and UniDock Vina, achieving high screening performance with minimal pose generation.

bioRxiv · Oct 10, 2025 · PreprintBioinformatics